title: Further analysis of correlates of protection from a phase 2a trial of the falciparum malaria vaccines RTS,S/AS01B and RTS,S/AS02A in malaria-naive adults.
authors.forename: Ally Ibrahim
authors.initials: AI
authors.lastname: Olotu
authors.forename: Gregory
authors.initials: G
authors.lastname: Fegan
authors.forename: Philip
authors.initials: P
authors.lastname: Bejon
mesh_terms: D000328:Adult; D000913:Antibodies, Protozoan / Q000096:biosynthesis / Q000097:blood; D018791:CD4 Lymphocyte Count; D006801:Humans; D017780:Malaria Vaccines / Q000276:immunology* / Q000592:standards; D016778:Malaria, Falciparum / Q000517:prevention & control*; D010963:Plasmodium falciparum / Q000276:immunology*; D012044:Regression Analysis
chemical_list: D000913:Antibodies, Protozoan; D017780:Malaria Vaccines